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Abstract: 
Four meroterpenoids [talarolutins A–D] and one known compound [purpurquinone A] were 
characterized from an endophytic fungal isolate of Talaromyces minioluteus (G413), which was 
obtained from the leaves of the medicinal plant milk thistle [Silybum marianum (L.) Gaertn. 
(Asteraceae)]. The structures of talarolutins A–D were determined by the analysis of various 
NMR and MS techniques. The relative and absolute configuration of talarolutin A was 
determined by X-ray diffraction analysis. A combination of NOESY data and comparisons of 
ECD spectra were employed to assign the relative and absolute configuration of the other 
analogs. Talarolutins B–D were tested for cytotoxicity against human prostate carcinoma (PC-3) 
cell line, antimicrobial activity, and induction of quinone reductase; no notable bioactivity was 
observed in any assay. 
Keywords: Meroterpenoid | Fungal endophyte | Talaromyces minioluteus | Milk thistle | Silybum 
marianum | Asteraceae 
Article: 
1. Introduction
Plant-based secondary metabolites (primarily flavonolignans) from the medicinal herb milk 
thistle [Silybum marianum (L.) Gaertn. (Asteraceae)] have been studied extensively (Althagafy 
et al., 2013, Davis-Searles et al., 2005, Graf et al., 2007, Gufford et al., 2014, Napolitano et al., 
2013, Polyak et al., 2010, Sy-Cordero et al., 2013). Recent studies that have explored the 
chemical and fungal diversity of endophytes associated with this plant have also yielded 
interesting results (El-Elimat et al., 2014b, Figueroa et al., 2014, Raja et al., 2015). In 
continuation of these investigations in search of new and/or biologically active natural products, 
an endophytic fungal isolate of Talaromyces minioluteus (G413), which was isolated from the 
leaves of milk thistle, was subjected to natural products chemistry techniques to yield four new 
meroterpenoids (Fig. 1), named here as talarolutins A–D (1–4), and one known compound, 
purpurquinone A (5) (Wang et al., 2011). Structurally diverse meroterpenoids with antimicrobial, 
antiviral, antitumor, immunomodulatory, and phytotoxic effects have been reported previously 
from various fungal sources (Geris and Simpson, 2009). Thus, compounds 2–4 were examined 
for biological activity in three assays, including cytotoxicity against a human prostate carcinoma 
(PC-3) cell line, antimicrobial activity, and induction of quinone reductase, but were all inactive. 
 
 
Fig. 1. Structures of talarolutins A–D (1–4) and purpurquinone A (5). 
 
2. Results and discussion 
 
Talarolutin A (1) had the molecular formula C21H30O5, yielding an index of hydrogen deficiency 
of seven. Signals for five methyl groups (four singlets and one doublet), two oxygenated 
methines, and a series of aliphatic protons, including five methylene and two methine units, were 
observed in the 1H NMR spectrum of 1 (Fig. S1, Supporting information and Table 1). In 
addition to the signals expected for these structural features, the 13C NMR spectrum showed 
resonances for three quaternary and four non-protonated sp2-hybridized carbons (Fig. 
S2 and Table 2). The sesquiterpenoid-derived portion of 1 was constructed by the analysis of 
COSY, HSQC, and HMBC NMR data (Table 1, Table 2, and S1). The upfield shifted methyl 
singlets, H3-14 (δH 1.08, 3H) and H3-13 (δH 1.02, 3H), showed common HMBC correlations to 
an oxygenated carbon, C-3 (δC 80.0), a quaternary carbon, C-4 (δC 38.4), and C-5 (δC 51.4). 
Further HMBC correlations from H-3 (δH 3.88, br s) to a ketone carbonyl, C-1 (δC 211.5) and C-
5, as well as, COSY correlations to H2-2 (δH3.35, dd, J = 13.5, 3.2 Hz and 2.22, dd, J = 13.5, 
3.7 Hz, 2H) were observed. These data, in conjunction with HMBC correlations from methyl 
singlet H3-15 (δH 1.24, 3H) to C-1, C-5, C-9 (δC 44.6), and quaternary carbon, C-10 (δC 51.7), 
supported the presence of a cyclohexanone ring system. COSY NMR data identified a spin 
system H-5/H2-6/H2-7 (Fig. S3), including two methylene units (δH 1.69 and 1.50, 2H, for H2-
6; δH 2.04 and 1.66, 2H, for H2-7). HMBC correlations from methyl protons, H3-12 (δH 1.26, s, 
3H) to C-7 (δC 39.7), an oxygenated quaternary carbon, C-8 (δC 83.4), and C-9 completed the 
decalin portion of the ring system of 1. 
 
Table 1. 1H NMR spectroscopic data (400 MHz) for 1–4 in CDCl3. 
# 1 2 3 4  
δH (mult., J) δH (mult., J) δH (mult., J) δH (mult., J) 
1 
 
3.70 (br s) 
  
2α 3.35 (dd, 13.5, 3.2) 2.19 (dt, 13.5, 2.5) 3.48 (d, 3.3) 5.76 (d, 10.3) 
2β 2.22 (dd, 13.5, 3.7) 1.96 (dt, 13.5, 2.7) 
  
3 3.88 (br s) 3.52 (br s) 3.27 (d, 3.3) 6.17 (d, 10.3) 
5 1.81 (dd, 12.7, 2.0) 1.78 (dd, 12.6, 2.0) 
  
6α 1.69 (m) 1.74 (m) 1.75 (dt, 13.9, 3.5) 1.79 (dd, 14.4, 3.6) 
6β 1.50 (m) 1.41 (m) 1.60 (m) 1.73 (ddd, 14.4, 4.1, 3.3) 
7α 2.04 (m) 2.06 (m) 2.21 (m) 2.19 (dt, 4.9, 14.1) 
7β 1.66 (m) 1.70 (m) 1.70 (dt, 12.8, 3.4) 1.82 (m) 
9 2.04 (m) 2.21 (dd, 13.0, 4.9) 2.64 (dd, 12.8, 4.5) 2.60 (dd, 12.8, 4.5) 
11α 2.96 (dd, 15.5, 4.5) 2.37 (dd, 15.2, 4.9) 3.04 (dd, 15.3, 4.5) 3.15 (dd, 15.5, 4.5) 
11β 1.91 (dd, 15.5, 12.7) 1.99 (dd, 15.2, 13.0) 1.98 (dd, 15.3, 12.8) 2.01 (dd, 15.5, 12.8) 
12 1.26 (s) 1.25 (s) 1.25 (s) 1.33 (s) 
13 1.02 (s) 1.01 (s) 1.29 (s) 1.25 (s) 
14 1.08 (s) 0.83 (s) 1.27 (s) 1.13 (s) 
15 1.24 (s) 0.83 (s) 1.23 (s) 1.297 (s) 
4′α 2.48 (dd, 16.9, 14.0) 2.49 (dd, 16.8, 14.0) 2.48 (dd, 16.9, 14.4) 2.49 (dd, 16.9, 14.0) 
4′β 2.35 (dd, 16.9, 3.2) 2.32 (dd, 16.8, 3.1) 2.36 (dd, 16.9, 2.9) 2.36 (dd, 16.9, 3.2) 
5′ 4.57 (dqd, 14.0, 6.3, 3.2) 4.54 (ddq, 14.0, 3.1, 6.3) 4.60 (ddq, 14.4, 2.9, 6.3) 4.60 (ddq, 14.0, 3.2, 6.3) 
6′ 1.43 (d, 6.3) 1.42 (d, 6.3) 1.43 (d, 6.3) 1.44 (d, 6.3) 
3-OH 1.54 (br s) 
   
5-OH 
  
2.68 (br d, 2.0) 1.44 (s) 
 
To complete the structural assignments of 1, HMBC correlations from H2-11 (δ 2.96, 
dd, J = 15.5, 4.5 Hz and 1.91, dd, J = 15.5, 12.7 Hz, 2H) to C-8, C-9, C-10, olefinic carbons, C-
1′ (δC 168.4) and C-2′ (δC 91.1), and ketone carbonyl carbon, C-3′ (δC 191.2) appended the α,β-
unsaturated carbonyl unit to the bicyclic ring, thereby securing the attachment of C-11 to C-2′. 
The placement of a methylene unit, H2-4′ (δH 2.48, dd, J = 16.9, 14.0 Hz and δ2.35, dd, J = 16.9, 
3.2 Hz, 2H), alpha to the ketone (C-3′) was supported by HMBC correlations from H2-4′ to C-2′ 
and C-3′. Multiplicity of H2-4′, COSY NMR data, and additional HMBC correlations from H2-4′ 
to C-5′ (δC 75.8) and C-6′ (δC 20.7) enabled the identification of the spin system, H2-4′/H-5′ /H3-
6′, including the methyl group (δH 1.43, d, J = 6.3 Hz, 3H, for H3-6′). Although an HMBC 
correlation from H-5′ (δH 4.57, dqd, J = 14.0, 6.3, 3.2 Hz) to C-1′ was not observed, the chemical 
shifts of C-1′ and C-5′ were consistent with an ether linkage between the two carbons, 
completing the modified pyranone-type ring system. A second ether linkage between carbons C-
8 and C-1′ accounted for the last remaining unsaturation, as well as the significant downfield 
chemical shift of C-1′ (δC168.4). Attempts to assign the absolute configuration of 1 using 
Mosher’s method resulted in degradation of the compound (Hoye et al., 2007). Fortunately, X-
ray diffraction analysis of a crystal obtained during the course of these studies not only 
confirmed the structure (Fig. 2), but also enabled the unambiguous assignment of the absolute 
configuration of 1 by employing the Flack parameter [F = 0.01 (18)] (Parsons and Flack, 2004). 
 
Table 2. 13C NMR spectroscopic data (100 MHz) for 1–4 in CDCl3.a 
# 1 2 3 4 
1 211.5 72.1 202.7 203.0 
2 42.8 29.8 54.5 124.2 
3 80.0 77.8 64.0 150.7 
4 38.4 38.0 37.7 42.0 
5 51.4 42.3 76.7 78.4 
6 19.6 19.4 25.1 25.2 
7 39.7 40.0 31.9 32.8 
8 83.4 84.7 82.8 82.9 
9 44.6 44.5 38.7 38.7 
10 51.7 41.5 56.9 53.6 
11 17.1 15.3 17.8 17.7 
12 20.9 20.71 20.2 20.5 
13 27.7 28.5 23.8 24.0 
14 22.2 21.8 23.4 25.6 
15 14.5 15.6 16.2 18.6 
1′ 168.4 168.9 168.4 168.4 
2′ 91.1 90.5 91.1 91.5 
3′ 191.2 191.5 191.3 191.3 
4′ 42.9 42.7 42.8 42.8 
5′ 75.8 75.6 75.9 75.8 
6′ 20.7 20.67 20.6 20.6 
a δ in ppm. 
 
 
Fig. 2. ORTEP drawing of the molecular structure of 1. 
 
The molecular formula of talarolutin B (2) was determined to be C21H32O5 (index of hydrogen 
deficiency of six) on the basis of HRESIMS data. The 1H and 13C NMR spectra of 2 (Figs. S4, 
S5 and Table 1, Table 2) closely resembled those of 1. However, an additional oxygenated 
methine signal (δC/δH 72.1/3.70 for H-1) was observed in the NMR spectra of 2that replaced the 
ketone carbonyl carbon observed in the 13C NMR spectrum of 1 (δC 211.5 for C-1). These 
changes were consistent with the reduction of the carbonyl group at position C-1 to a secondary 
alcohol in 2 and accounted for the only key difference in the structure of talarolutin B (2), 
including one less degree of unsaturation. The small J-values observed for H-1, resulting in a 
broad peak in the 1H NMR spectrum (Fig. S4) supported the axial orientation of the hydroxy 
group. NOESY correlations between H-1 and H3-15/H3-14 (δH 0.83; overlapping signals) as well 
as between H-3, H3-14 (δH 0.83), and H3-13 (δH1.01) were also consistent with a 1, 3-diaxial 
orientation for the hydroxy groups in 2. Assuming identical relative and absolute configuration at 
the in-common asymmetric centers between 1 and 2 (based on biosynthetic origins), C-1 was 
assigned the S-configuration by analysis of the proton coupling constants and NOESY NMR data 
(Fig. S6). 
 
Inspection of the 1H NMR spectrum (Fig. S7 and Table 1) of talarolutin C (3) showed signals 
corresponding to the structural features similar to those observed for 1 and 2. The presence of a 
pair of coupled doublets (δH 3.48, d, J = 3.3 Hz for H-2 and δH 3.27, d, J = 3.3 Hz for H-3), 
characteristic of epoxide protons in the 1H NMR spectrum of 3, accounted for one of the key 
differences. Corresponding carbon signals (δC 54.5 for C-2 and δC 64.0 for C-3) were also 
observed in the 13C NMR spectrum (Fig. S8 and Table 2). The position of the C-2/C-3 epoxide 
group was supported by HMBC correlations from H-2 to C-1 (δC 202.7) and C-10 (δC 56.9), as 
well as from H-3 to C-1, C-4 (δC 37.7), C-5 (δC76.7), and C-14 (δC 23.4). A NOESY correlation 
between H-2 and H-3 suggested a syn-epoxide moiety, and an additional correlation between H-2 
and H3-15 (δH 1.23) placed these protons on the same face of the six-membered ring system. 
Additionally, another difference between 1 and 3 was oxygenation at C-5 in 3 relative to 1, 
resulting in a downfield-shift of C-5 (δC 76.7) in 3 relative to 1 (δC 51.4) and the appearance of 
an additional hydroxy group (δH 2.68 for 5-OH) at the ring junction; the HRESIMS data 
[m/z377.1942 (M+H)+] were consistent with the molecular formula (C21H28O6) of talarolutin C 
(3), including an extra oxygen moiety relative to the formula of 1. NOESY correlations between 
H-6α (δH 1.75), H3-13 (δH 1.29), and 5-OH, as well as from methylene proton, H-6β (δH 1.60) to 
pseudo-axially oriented methyl groups, H3-15, H3-14 (δH 1.27), and H3-12 (δH 1.25) supported 
the trans-ring junction for terpene-derived bicyclic ring system (Fig. S6); while not definitive, 
the absence of NOESY correlations between 5-OH and H3-15 were consistent with this 
assignment. The remaining asymmetric centers that were common with 1 and 2 were assigned 
analogous absolute configurations, as discussed previously. 
 
In the 1H and 13C NMR spectra (Figs. S9, S10 and Table 1, Table 2) of talarolutin D (4), the 
epoxide signals observed in 3 were replaced by resonances characteristic of a double bond 
(δC/δH 124.2/5.76, d, J = 10.3 and δC/δH 150.7/6.17, d, J = 10.3 for C-2/H-2 and C-3/H-3, 
respectively). The molecular formula of 4 was determined to be C21H28O5 (eight unsaturations), 
which was consistent with such a substitution. The remaining structural features were similar 
to 3 and since no new asymmetric centers were generated, an analogous relative configuration 
was proposed for 4. A SciFinder search showed compounds 3 and 4 to be a part of an industrial 
catalog. However, lack of reported NMR data as well as absence of relative and absolute 
configuration assignment did not allow unambiguous identification of these compounds. 
Therefore, 3 and 4 are considered new natural products and have been fully characterized in this 
report. The experimental ECD spectra (Fig. 3) for 1–4 showed a comparable trend supporting the 
assignment of all talarolutin analogs to the same enantiomeric series. 
 
 
Fig. 3. Experimental ECD spectra of 1–4. 
 
As with previous research on compounds isolated from endophytes of milk thistle (Raja et al., 
2015), the compounds 2–4 were evaluated for cytotoxicity against the human prostate carcinoma 
(PC-3) cell line but all were inactive (IC50 values >25 μM). They were also examined in a suite 
of antimicrobial assays, but did not show any effects (MIC values >100 μg/mL) 
against Staphylococcus aureus, Escherichia coli, Mycobacterium smegmatis, Candida albicans, 
and Aspergillus niger. The structural features of talarolutins bore close resemblance to recently 
reported marine natural products, penicillipyrones A and B (Liao et al., 2014). The latter of these 
was reported to show significant induction of quinone reductase. Therefore, compounds 2–
4 were also tested for biological activity in this assay but were found to be ineffective at the 
highest concentration tested (25 μM). Due to low sample amounts, compounds 1 and 5 were not 
evaluated for any biological activity in various assays. Compound 5 was originally isolated 
from Talaromyces purpureogenus and tested for bioactivity against influenza A virus (H1N1) 
but was found to be inactive (Wang et al., 2011). 
 
3. Conclusion 
 
Examination of an endophytic fungal isolate of milk thistle resulted in isolation of four new 
natural products from T. minioluteus. Biosynthetically, these compounds appear to be assembled 
by a combination of terpene-derived farnesyl moiety and a pyrone unit (Liao et al., 2014), and 
there is a growing interest in the biosynthesis of meroterpenoids due to their hybrid terpene and 
polyketide origins (Itoh et al., 2010). Although inactive in a few available assays, the new 
compounds append to only a handful of other reports of the chemistry from T. minioluteus 
(Ngokpol et al., 2015, Yilmaz et al., 2014). The mycology of the genus Talaromyces, in addition 
to a brief summary of the few secondary metabolites reported from T. minioluteus, has been 
reviewed recently (Yilmaz et al., 2014). Miniolins A–C were reported from an epigenetically 
modified culture of Penicillium minioluteum (now T. minioluteus) (Tang et al., 2015). Our 
ongoing studies of endophytes of milk thistle and other medicinal plants have also yielded a suite 
of secondary metabolites belonging to structurally diverse classes (Bussey et al., 2015, El-Elimat 
et al., 2014b, Figueroa et al., 2014, Kaur et al., 2016, Raja et al., 2015). These observations 
support the overall goal of exploring this ecological group for new secondary metabolites. 
 
4. Experimental 
 
4.1. General experimental procedures 
 
NMR experiments were conducted using an Agilent-700 and/or JEOL ECS-400 spectrometers 
(700 or 400 MHz for 1H NMR and 175 or 100 MHz for 13C NMR; Agilent Technologies, Santa 
Clara, CA, USA; JEOL Ltd., Tokyo, Japan). HRESIMS data were collected using an 
electrospray ionization (ESI) source coupled to a Q-ToF Premier mass spectrometer (Waters 
Corp., Milford, MA, USA) or a LTQ Orbitrap XL system (Thermo Fisher Scientific, San Jose, 
CA, USA) in positive and/or negative ionization modes by direct injection or via a liquid 
chromatography/autosampler system comprised of Acquity UPLC system (Waters Corp.). A 
CombiFlash Rf system using a RediSep Rf Si-gel Gold column (both from Teledyne-Isco, 
Lincoln, NE, USA) was employed for normal phase flash column chromatography (CC). HPLC 
separations were performed utilizing a Varian Prostar HPLC system (Varian Inc., Palo Alto, CA, 
USA) equipped with Prostar 210 pumps and a Prostar 335 photodiode array detector, using 
Galaxie Chromatography Workstation software (version 1.9.3.2, Varian Inc.). Kinetex C18 
(Phenomenex, Torrance, CA, USA; 5 μm; columns of dimensions 250 × 21.2 mm and 
250 × 4.6 mm) were used for preparative and analytical HPLC. YMC ODS-A (Waters Corp.; 
5 μm; columns of dimensions 250 × 10 mm and 250 × 4.6 mm) columns were used for semi-
preparative and analytical HPLC in selected cases. For UPLC analysis, a BEH C18 (Waters 
Corp.; 1.7 μm; 50 × 2.1 mm) column was used. Optical rotation data were acquired on a Rudolph 
Research Autopol III polarimeter (Rudolph Research Analytical, Flanders, NJ, USA). ECD data 
were collected using an Olis DSM 17 CD spectrophotometer (Olis, Bogard, GA, USA). UV data 
were obtained using a Varian Cary 100 Bio UV–vis spectrophotometer (Varian Medical 
Systems, Palo Alto, CA, USA). IR data were collected using PerkinElmer Spectrum One with 
Universal ATR attachment (PerkinElmer, Inc., Waltham, MA, USA). The solvents were 
obtained from Fisher Scientific. 
 
4.2. Isolation and identification of fungal strain 
 
Fungal strain G413 was isolated as an endophyte from healthy surface sterilized leaves of milk 
thistle using procedures outlined previously (Figueroa et al., 2014). Based on morphology, it was 
evident that strain G413 belonged to T. minioluteus (Dierckx) Samson, Yilmaz, Frisvad, and 
Seifert (Yilmaz et al., 2014) (Fig. S11). Micromorphology of conidiophore and conidia agrees 
well with the original protologue presented recently in a polyphasic taxonomic study of the 
genus Talaromyces (Yilmaz et al., 2014). 
 
For molecular identification of strain G413, two gene regions were sequenced. First, the nuclear 
ribosomal internal transcribed spacer region (ITS) was sequenced as it has been identified as a 
barcoding marker for fungi (Schoch et al., 2012). In addition to the ITS region, sequence data 
was obtained from the RNA polymerase II largest subunit gene (RPB1). The RPB1 region has 
been utilized in phylogenetic studies of subgenus Biverticillium (Samson et al., 2011). DNA 
extraction, PCR amplification, and phylogenetic analysis were performed following methods 
summarized earlier (El-Elimat et al., 2013, Figueroa et al., 2014). The RPB1 region was 
amplified using primers RPB1-F1843 and RPB1-R3096 and PCR protocols outlined by 
Houbraken and Samson (2011) with some modifications. The first PCR reaction was carried out 
in 25 μL containing 3 μL template DNA, 2.5 μL BSA (New England BioLabs Inc), 2.5 μL 50% 
DMSO (Sigma), and 1 μL of each 10 μM forward (RPB1-F1843) and reverse (RPB1-R3096) 
primer. The rest of the volume was made up to 25 μL by adding molecular biology grade H2O 
from Fisher Scientific. After the first PCR, 1.5 μL PCR product was used to run a second PCR 
using the same protocol as the first PCR reaction. The PCR products were then run on an 
ethidium bromide-stained 1% agarose gel (Fisher Scientific) along with a 1 kb DNA ladder 
(Promega) to estimate the size of the amplified band. PCR products were finally purified using a 
Wizard SV Gel and PCR Clean-up System. Bidirectional Sanger sequencing of the purified PCR 
products was performed at Eurofins Genomics (http://www.operon.com/default.aspx) using 
BigDye Terminator v3.1 cycle sequencing. Sequences are edited using Sequencher 5.2.3 (Gene 
Codes Corp.). BLAST searches were then performed against the NCBI GenBank database 
separately using both the ITS region as well as the RPB1 gene. Based on the ITS region BLAST 
search, against the TYPE database (Schoch et al., 2014), the closest hits were T. minioluteus 
(CBS 642.68; from TYPE material) GenBank NR_121527.1; Identities = 561/575 (98%); Gaps = 
12/572 (2%), Penicillium samsonii (CBS 137.84) GenBank JN899369; Identities = 562/571 
(98%); Gaps = 9/571 (1%), and Penicillium purogenum var. rubrisclerotium (CBS 270.35) 
GenBank JN899381; Identities = 560/571 (98%); Gaps = 10/571 (1%). Similar results were 
obtained using the RPB1 region. According to Samson et al., 2011, Yilmaz et al., 2014 P. 
samsonii and P. purogenum var. rubrisclerotium are synonymous with T. minioluteus. The RBP1 
sequences from the top BLAST search based on sequence similarity were downloaded and 
incorporated into an alignment with RPB1 sequence from G413 for a maximum likelihood (ML) 
analysis using RAxML (Stamatakis, 2006). Results from both the BLAST search and ML 
analysis suggests that strain G413 can be identified as T. minioluteus [Pezizomycotina; 
Trichocomaceae]; the sequence from strain G413 forms a strong clade with 99% bootstrap 
statistical support with T. minioluteus, P. purogenum var. rubrisclerotium, and P. samsonii (Fig. 
S12). The fungal culture is maintained at the University of North Carolina at Greensboro, 
Department of Chemistry and Biochemistry Fungal Culture Collection, and a voucher specimen 
(G413) is deposited there. The sequence data were deposited in the GenBank (ITS: KM215653; 
RPB1: KU363961). 
 
4.3. Fermentation and extraction 
 
For extractions, fungal cultures were grown on rice using procedures detailed previously (El-
Elimat et al., 2014a). Briefly, seed cultures grown on malt extract agar (MEA; Difco) medium 
were excised from the leading edge of the colony and transferred to a liquid medium containing 
2% soy peptone, 2% dextrose and 1% yeast extract (YESD). Following incubation (7 d) at 22 °C 
with agitation, the culture was used to inoculate rice media (50 mL) prepared using rice and 
twice the volume of rice with H2O in a 250 mL Erlenmeyer flask. This was incubated at 22 °C 
until the cultures showed good growth (14–21 d). To produce larger amounts of material, three 
250 mL Erlenmeyer flasks were inoculated in an identical manner using one seed culture for 
each flask. 
 
To each solid-substrate fermentation culture (G413) grown on rice (three flasks), CH3OH:CHCl3 
(60 mL, 1:1 v/v) was added. The culture was chopped into small pieces with a spatula and 
shaken overnight (∼125 rpm at rt) using a rotary shaker. The sample was vacuum filtered, and 
the remaining residues were washed with small volumes of CH3OH:CHCl3 (1:1 v/v). The 
filtrates from the three flasks were combined and CHCl3:H2O (540 mL, 1:1 v/v) were added, 
followed by stirring for 30 min. The organic layer was collected and evaporated to dryness under 
reduced pressure. The organic extract was further partitioned between CH3OH:CH3CN (300 mL, 
1:1 v/v) and hexanes (300 mL). The CH3OH:CH3CN layer was evaporated to dryness in vacuum 
to yield crude extract (802 mg). 
 
4.4. Isolation 
 
The organic extract (802 mg) was dissolved in a minimum amount of CHCl3:CH3OH (1:1 v/v), 
adsorbed onto Celite 545, and subjected to flash normal-phase CC using a gradient solvent 
system of hexane:CHCl3:CH3OH at 30 mL/min flow rate and 61 column volumes over 34.1 min 
to afford three fractions. Fraction 2 (70 mg) was subjected to preparative RP HPLC [Kinetex-
C18 column, linear gradient elution using CH3CN:H2O (containing 0.1% HCOOH): 40–80% 
CH3CN for 20 min; λ = 210 and 254 nm; 21.2 mL/min] to yield 4(16.8 mg; tR = 5.5 min) and a 
mixture of 3 and 4 (14.6 mg; tR = 6.0 min). The mixture of 3and 4 was then purified using prep 
RP HPLC [Kinetex-C18 column, isocratic CH3CN:H2O (containing 0.1% HCOOH), 35:65 v/v, 
21.2 mL/min] affording pure talarolutin C (3, 8.5 mg, tR = 11.0 min) and talarolutin D (4; 
3.0 mg; tR = 9.5 min). Preparative RP HPLC [Kinetex-C18 column, gradient elution using 
CH3CN:H2O (containing 0.1% HCOOH): 40–60% CH3CN for 20 min; 60–80% CH3CN for 
10 min; λ = 210 and 254 nm; 21.2 mL/min] of fraction 3 (480 mg) resulted in isolation 
of 4 (14.7 mg; tR = 6.0 min) and mixtures of 1(12.0 mg; tR = 6.5 min), 5 (11.7 mg; tR = 7.0 min), 
and 2 (19.5 mg; tR = 9.5 min). Compounds 1, 2, and 5 were further purified using prep RP HPLC 
[Kinetex-C18 column, 21.2 mL/min] affording pure talarolutin A [1, 1.7 mg, tR = 11.5 min; 
isocratic CH3CN:H2O (containing 0.1% HCOOH), 35:65 v/v], talarolutin B [2, 6.9 mg, tR = 12.5 
min; isocratic CH3CN:H2O (containing 0.1% HCOOH) 35:65 v/v], and purpurquinone A [5, 1.2 
mg, tR = 12.5 min; isocratic CH3CN:H2O (containing 0.1% HCOOH) 40:60 v/v]. The HRMS and 
1H NMR data for 5 were fully consistent with those reported in literature (Wang et al., 2011). To 
achieve ⩾95% pure sample of 2, an additional purification step employing semi-preparative RP 
HPLC [YMC-C18 column, isocratic CH3CN:H2O (containing 0.1% HCOOH), 40:60 v/v; λ = 210 
and 254 nm; 3 mL/min] was carried out to yield pure talarolutin B (2, 5.7 mg, tR = 29.0 min). 
 
4.5. Talarolutin A (1) 
 
Colorless crystals from CH3OH:CH3CN (1:1 v/v); [α]D23=+237(c=005,CH3OH); UV/Vis 
(CH3OH) λmax (log ε) 205 (3.1), 272 (4.0) nm; ECD (92 μM, CH3OH) λmax (Δε) 267 (−12), 289 
(+71) nm; for 1H, 13C, and HMBC NMR spectroscopic data, see Table 1, Table 2, and S1 
respectively; HRESIMS m/z 363.2151 [M+H]+ (calcd. for C21H31O5, 363.2166). 
 
4.6. Talarolutin B (2) 
 
Colorless powder; [α]D23=+200(c=0.11,CH3OH); UV/Vis (CH3OH) λmax (log ε) 208 (3.0), 271 
(3.7) nm; IR (diamond) νmax 2971, 1581, 1423, 1052, 1033 cm−1; ECD (183 μM, CH3OH) λmax 
(Δε) 266 (−9), 287 (+75) nm; for 1H, 13C, and HMBC NMR spectroscopic data, see Table 1, 
Table 2, and S1 respectively; HRESIMS m/z 365.2306 [M+H]+ (calcd. for C21H33O5, 365.2322). 
 
4.7. Talarolutin C (3) 
 
Colorless powder; [α]D23=+124(c=0.15,CH3OH); UV/Vis (CH3OH) λmax (log ε) 211 (2.6), 271 
(3.6) nm; IR (diamond) νmax 2998, 1587, 1422, 1186, 1139, 1052 cm−1; ECD (177 μM, CH3OH) 
λmax (Δε) 266 (−8), 288 (+38), 328 (−3) nm; for 1H, 13C, and HMBC NMR spectroscopic data, 
see Table 1, Table 2, and S1 respectively; HRESIMS m/z 377.1942 [M+H]+ (calcd. for 
C21H29O6, 377.1959). 
 
4.8. Talarolutin D (4) 
 
Colorless oil; [α]D25=+214(c=0.24,CH3OH); UV/Vis (CH3OH) λmax (log ε) 227 (3.6), 272 (3.7) 
nm; IR (diamond) νmax 1689, 1586, 1421, 1186 cm−1; ECD (185 μM, CH3OH) λmax (Δε) 238 
(+23), 288 (+53), 331 (−12) nm; for 1H, 13C, and HMBC NMR spectroscopic data, see Table 1, 
Table 2, and S1 respectively; HRESIMS m/z 361.1997 [M+H]+ (calcd. for C21H29O5, 361.2010). 
 
4.9. X-ray diffraction analysis of talarolutin A (1) 
 
A specimen of C21H30O5, approximate dimensions 0.005 mm × 0.010 mm × 0.090 mm, was used 
for the X-ray crystallographic analysis. The X-ray intensity data were measured. Intensity data 
were collected at 150K on a D8 goniostat equipped with a Bruker PHOTON100 CMOS detector 
at Beamline 11.3.1 at the Advanced Light Source (Lawrence Berkeley National Laboratory) 
using synchrotron radiation tuned to λ = 1.2399 Å. For data collection, frames were measured for 
a duration of 1-s at 0.5° intervals of ω with a maximum 2θ value of ∼60°. The total exposure 
time was 0.73 h. The frames were integrated with the Bruker SAINT software package using a 
narrow-frame algorithm. The integration of the data using a monoclinic unit cell yielded a total 
of 11510 reflections to a maximum θ angle of 50.93° (0.80 Å resolution), of which 3748 were 
independent (average redundancy 3.071, completeness = 99.1%, Rint = 4.93%, Rsig = 5.08%) and 
3231 (86.21%) were greater than 2σ(F2). The final cell constants of a = 13.0307(13) Å, 
b = 5.9960(6) Å, c = 13.6512(13) Å, β = 118.418(5)°, volume = 938.07(16) Å3, are based upon 
the refinement of the XYZ-centroids of 7139 reflections above 20 σ(I) with 
5.920° < 2θ < 96.37°. Data were corrected for absorption effects using the multi-scan method 
(SADABS). The ratio of minimum to maximum apparent transmission was 0.804. The calculated 
minimum and maximum transmission coefficients (based on crystal size) are 0.9670 and 0.9980. 
The final anisotropic full-matrix least-squares refinement on F2 with 244 variables converged 
at R1 = 4.15%, for the observed data and wR2 = 10.03% for all data. The goodness-of-fit was 
1.035. The largest peak in the final difference electron density synthesis was 0.204 e−/Å3 and the 
largest hole was −0.299 e−/Å3 with an RMS deviation of 0.043 e−/Å3. On the basis of the final 
model, the calculated density was 1.280 g/cm3 and F(0 0 0), 390 e−. Crystal data have been 
deposited with the Cambridge Crystallographic Data Centre and can be accessed using the 
deposition number, CCDC 1046537. 
 
4.10. Bioassays 
 
Human prostate carcinoma PC-3 cells were obtained from American Type Culture Collection 
(Manassas, VA) and cultured under ATCC recommended conditions. The effect of pure 
compounds on viability of PC-3 cells was determined by the methods described previously (Raja 
et al., 2015). Minimal inhibitory concentrations (MICs) of compounds 2–4in antimicrobial 
assays were determined using the methods outlined previously (Ayers et al., 2012). For the 
quinone reductase assay, the commercially available NQO activity assay kit from Abcam 
(Cambridge, MA) was utilized exactly as recommended by the vendor. 
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Appendix A. Supplementary data 
 
Figure S1. 1H NMR spectrum of talarolutin A (1) in CDCl3 (700 MHz). 
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Figure S2. 13C NMR spectrum of talarolutin A (1) in CDCl3 (175 MHz).
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Figure S3. Key spin systems based on the COSY NMR correlations (▬) for talarolutin A (1). 
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Figure S4. 1H NMR spectrum of talarolutin B (2) in CDCl3 (700 MHz). 
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Figure S5. 13C NMR spectrum of talarolutin B (2) in CDCl3 (175 MHz).
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Figure S6. Key NOESY correlations of (a) talarolutins B (2) and (b) C (3).
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Figure S7. 1H NMR spectrum of talarolutin C (3) in CDCl3 (700 MHz). 
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Figure S8. 13C NMR spectrum of talarolutin C (3) in CDCl3 (100 MHz). 
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Figure S9. 1H NMR spectrum of talarolutin D (4) in CDCl3 (700 MHz). 
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Figure S10. 13C NMR spectrum of talarolutin D (4) in CDCl3 (100 MHz). 
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Figure S11. A: Reverse colony on MEA; brownish orange; B and C: Biverticillate conidiophores and smooth ellipsoidal conidia. 
Measure bars = 20 µm. 
 
Figure S12. Phylogram of the most likely tree (-lnL = 1561.75) from a RAxML analysis of 75 taxa based on 
RPB1 sequence data (785 bp). Numbers refer to RAxML bootstrap support values ≥ 70% based on 1000 
replicates. Strain G413 is identified as Talaromyces minioluteus (Bold, highlighted in gray). The symbol (\\) 
indicates, the branches were shortened for illustration purpose.  A 30d old culture on Potato Dextrose Agar media 
is shown. Bar indicates nucleotide substitution per site. 
Table S1. HMBC NMR data (400 MHz) of talarolutins A‒D (1‒4) in CDCl3. 
 1 2 3 4 
# HMBC (H→ #C) HMBC (H→ #C) HMBC (H→ #C) HMBC (H→ #C) 
1  2 (wk), 3, 5, 15 (wk)   
2α 1, 3  1, 10 1 (wk), 4, 10, 13 (wk), 14 (wk) 
2β 1, 3, 4, 10 1, 3, 4, 10   
3 1, 5, 13, 14 (wk) 1, 2 (wk), 5, 13 (wk), 14 (wk) 1, 4, 5, 14 1, 4, 5, 13, 14 
5 1 (wk), 3 (wk), 4, 6, 7, 9, 10, 13, 14, 15 4, 6, 7, 9 (wk), 13, 14 (wk), 15   
6α 4, 5, 8, 10 5 (wk), 8, 10 5, 7, 8, 10 (wk) 5, 8, 9 
6β 5, 7, 8, 10  7, 8 (wk) 5, 7, 8, 10 
7α 8, 9, 12 5, 8 (wk), 9, 12 (wk) 6, 8, 12 6, 8, 11 (wk), 12 
7β 5, 6, 8, 12 6, 8, 12 5, 6, 8 5, 9, 11 (wk), 12 
9 1, 7 (wk), 8, 10, 11, 12, 15, 2′ (wk) 1 (wk), 5 (wk), 8, 10, 12, 15, 2′ (wk) 1, 8, 10, 11, 12, 15 1, 8, 10, 12, 15 
11α 8, 9, 1′, 2′, 3′ 8, 9, 1′, 2′ 8, 9, 1′, 2’, 3’ 8, 9, 1′, 2′, 3′ 
11β 8 (wk), 9, 10, 1′, 2′ 9, 10, 1′, 2′ 9, 10 (wk), 1′, 2’ 8, 9, 10,  1’, 2’ 
12 7, 8, 9 7, 8, 9 7, 8, 9 7, 8, 9 
13 3, 4, 5, 14 3, 4, 5, 14 3, 4, 5, 14 3, 4, 5, 14 
14 3, 4, 5, 13 3, 4, 5, 13 3, 4, 5, 13 3, 4, 5, 13 
15 1, 5, 9, 10 1, 5, 9, 10 1, 5, 9, 10 1, 5, 9, 10 
4′α 5′, 3′, 6′ 5′, 3′, 6′ 5′, 3′, 6′ 5′, 3′, 6′ 
4′β 2′ (wk), 3′ 2′, 3′ 2′, 3′ 2′ (wk), 3′ 
5′ 3′ (wk), 6′ (wk) 3′ (wk), 6′ (wk) 3′ (wk), 6′ (wk)  
6′ 1′ (wk), 3′ (wk), 4′, 5′ 1′ (wk), 3′ (wk), 4′, 5′ 1′ (wk), 3′ (wk), 4′, 5′ 1′ (wk), 3′ (wk), 4′, 5′ 
5-OH   4, 5, 6  
X-ray Crystallographic Analysis of 1 
 
 
Table S2. Sample and crystal data for 1.  
Identification code Talarolutin A 
Chemical formula C21H30O5 
Formula weight 362.45 
Temperature 150(2) K 
Wavelength 1.23990 Å 
Crystal size 0.005 x 0.010 x 0.090 mm 
Crystal system monoclinic 
Space group P 1 21 1 
Unit cell dimensions a = 13.0307(13) Å α = 90° 
 b = 5.9960(6) Å β = 118.418(5)° 
 c = 13.6512(13) Å γ = 90° 
Volume 938.07(16) Å3  
Z 2 
Density (calculated) 1.283 g/cm3 
Absorption coefficient 0.371 mm-1 
F(000) 392 
 
Table S3. Data collection and structure refinement for 1. 
Theta range for data collection 2.96 to 50.93° 
Index ranges -16<=h<=16, -7<=k<=7, -17<=l<=17 
Reflections collected 11510 
Independent reflections 3748 [R(int) = 0.0493] 
Coverage of independent reflections 99.1% 
Absorption correction multi-scan 
Max. and min. transmission 0.9980 and 0.9670 
Refinement method Full-matrix least-squares on F2 
Refinement program SHELXL-2013 (Sheldrick, 2013) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 3748 / 1 / 244 
Goodness-of-fit on F2 1.035 
Δ/σmax 0.001 
Final R indices 3231 data; I>2σ(I) R1 = 0.0415, wR2 = 0.0960 
 all data R1 = 0.0513, wR2 = 0.1003 
Weighting scheme w=1/[σ
2(Fo2)+(0.0540P)2+0.0527P] 
where P=(Fo2+2Fc2)/3 
Absolute structure parameter 0.01(18) 
Largest diff. peak and hole 0.204 and -0.299 eÅ-3 
R.M.S. deviation from mean 0.043 eÅ-3 
 
Table S4. Atomic coordinates (x 104) and equivalent isotropic atomic displacement 
parameters (Å2 x 103) for 1.   
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.  
 x/a y/b z/c U(eq) 
C(1) 3852(2) 1100(4) 9011(2) 24(1) 
O(1) 4603(2) 2347(3) 9644(1) 31(1) 
C(2) 2875(2) 324(5) 9235(2) 30(1) 
C(3) 1730(2) 1411(5) 8375(2) 32(1) 
O(3) 1805(2) 3775(4) 8507(2) 39(1) 
C(4) 1443(2) 904(5) 7163(2) 28(1) 
C(5) 2533(2) 1536(4) 7018(2) 24(1) 
C(6) 2343(2) 1334(5) 5821(2) 29(1) 
C(7) 3314(2) 2594(5) 5716(2) 29(1) 
C(8) 4515(2) 1699(4) 6519(2) 28(1) 
O(8) 5321(1) 3483(3) 6525(1) 31(1) 
C(9) 4712(2) 1590(4) 7724(2) 24(1) 
C(10) 3717(2) 439(4) 7864(2) 23(1) 
C(11) 5949(2) 740(4) 8483(2) 26(1) 
C(1') 6412(2) 3421(5) 7358(2) 30(1) 
C(2') 6802(2) 2086(5) 8270(2) 28(1) 
C(3') 8036(2) 1871(5) 8973(2) 31(1) 
O(3') 8483(2) 513(4) 9750(2) 41(1) 
C(4') 8801(2) 3344(5) 8685(2) 38(1) 
C(5') 8173(2) 5450(5) 8115(2) 36(1) 
O(5') 7057(2) 4883(3) 7140(2) 34(1) 
C(12) 4805(3) -387(5) 6068(2) 36(1) 
C(13) 396(2) 2354(6) 6377(2) 39(1) 
C(14) 1053(2) -1537(5) 6887(2) 36(1) 
C(15) 3746(2) -2131(4) 7768(2) 28(1) 
C(6') 8821(3) 6900(6) 7689(3) 46(1) 
 
  
Table S5. Bond lengths (Å) for 1.   
C(1)-O(1) 1.208(3) C(11)-C(2') 1.509(3) 
C(1)-C(2) 1.517(3) C(11)-H(11A) 0.99 
C(1)-C(10) 1.542(3) C(11)-H(11B) 0.99 
C(2)-C(3) 1.536(4) C(1')-O(5') 1.342(3) 
C(2)-H(2A) 0.99 C(1')-C(2') 1.359(4) 
C(2)-H(2B) 0.99 C(2')-C(3') 1.434(4) 
C(3)-O(3) 1.426(4) C(3')-O(3') 1.241(3) 
C(3)-C(4) 1.543(4) C(3')-C(4') 1.516(4) 
C(3)-H(3) 1 C(4')-C(5') 1.505(4) 
O(3)-H(3A) 0.88(3) C(4')-H(4'A) 0.99 
C(4)-C(14) 1.537(4) C(4')-H(4'B) 0.99 
C(4)-C(13) 1.542(4) C(5')-O(5') 1.469(3) 
C(4)-C(5) 1.571(3) C(5')-C(6') 1.508(4) 
C(5)-C(6) 1.537(3) C(5')-H(5') 1 
C(5)-C(10) 1.566(3) C(12)-H(12A) 0.98 
C(5)-H(5) 1 C(12)-H(12B) 0.98 
C(6)-C(7) 1.537(3) C(12)-H(12C) 0.98 
C(6)-H(6A) 0.99 C(13)-H(13A) 0.98 
C(6)-H(6B) 0.99 C(13)-H(13B) 0.98 
C(7)-C(8) 1.519(4) C(13)-H(13C) 0.98 
C(7)-H(7A) 0.99 C(14)-H(14A) 0.98 
C(7)-H(7B) 0.99 C(14)-H(14B) 0.98 
C(8)-O(8) 1.497(3) C(14)-H(14C) 0.98 
C(8)-C(12) 1.519(4) C(15)-H(15A) 0.98 
C(8)-C(9) 1.541(3) C(15)-H(15B) 0.98 
O(8)-C(1') 1.333(3) C(15)-H(15C) 0.98 
C(9)-C(11) 1.529(4) C(6')-H(6'A) 0.98 
C(9)-C(10) 1.559(3) C(6')-H(6'B) 0.98 
C(9)-H(9) 1 C(6')-H(6'C) 0.98 
C(10)-C(15) 1.549(4)   
 
Table S6. Bond angles (°) for 1.  
O(1)-C(1)-C(2) 121.2(2) C(2')-C(11)-C(9) 109.1(2) 
O(1)-C(1)-C(10) 123.2(2) C(2')-C(11)-H(11A) 109.9 
C(2)-C(1)-C(10) 115.1(2) C(9)-C(11)-H(11A) 109.9 
C(1)-C(2)-C(3) 108.6(2) C(2')-C(11)-H(11B) 109.9 
C(1)-C(2)-H(2A) 110 C(9)-C(11)-H(11B) 109.9 
C(3)-C(2)-H(2A) 110 H(11A)-C(11)-H(11B) 108.3 
C(1)-C(2)-H(2B) 110 O(8)-C(1')-O(5') 108.6(2) 
C(3)-C(2)-H(2B) 110 O(8)-C(1')-C(2') 125.5(2) 
H(2A)-C(2)-H(2B) 108.3 O(5')-C(1')-C(2') 125.9(2) 
O(3)-C(3)-C(2) 110.0(2) C(1')-C(2')-C(3') 118.5(2) 
O(3)-C(3)-C(4) 107.3(2) C(1')-C(2')-C(11) 120.2(2) 
C(2)-C(3)-C(4) 112.8(2) C(3')-C(2')-C(11) 121.2(2) 
O(3)-C(3)-H(3) 108.9 O(3')-C(3')-C(2') 123.5(2) 
C(2)-C(3)-H(3) 108.9 O(3')-C(3')-C(4') 120.3(2) 
C(4)-C(3)-H(3) 108.9 C(2')-C(3')-C(4') 116.2(2) 
C(3)-O(3)-H(3A) 109(2) C(5')-C(4')-C(3') 111.1(2) 
C(14)-C(4)-C(13) 106.6(2) C(5')-C(4')-H(4'A) 109.4 
C(14)-C(4)-C(3) 109.5(2) C(3')-C(4')-H(4'A) 109.4 
C(13)-C(4)-C(3) 108.5(2) C(5')-C(4')-H(4'B) 109.4 
C(14)-C(4)-C(5) 114.3(2) C(3')-C(4')-H(4'B) 109.4 
C(13)-C(4)-C(5) 109.3(2) H(4'A)-C(4')-H(4'B) 108 
C(3)-C(4)-C(5) 108.4(2) O(5')-C(5')-C(4') 109.5(2) 
C(6)-C(5)-C(10) 110.8(2) O(5')-C(5')-C(6') 106.2(2) 
C(6)-C(5)-C(4) 114.7(2) C(4')-C(5')-C(6') 114.7(2) 
C(10)-C(5)-C(4) 116.0(2) O(5')-C(5')-H(5') 108.8 
C(6)-C(5)-H(5) 104.7 C(4')-C(5')-H(5') 108.8 
C(10)-C(5)-H(5) 104.7 C(6')-C(5')-H(5') 108.8 
C(4)-C(5)-H(5) 104.7 C(1')-O(5')-C(5') 113.89(19) 
C(5)-C(6)-C(7) 109.7(2) C(8)-C(12)-H(12A) 109.5 
C(5)-C(6)-H(6A) 109.7 C(8)-C(12)-H(12B) 109.5 
C(7)-C(6)-H(6A) 109.7 H(12A)-C(12)-H(12B) 109.5 
C(5)-C(6)-H(6B) 109.7 C(8)-C(12)-H(12C) 109.5 
C(7)-C(6)-H(6B) 109.7 H(12A)-C(12)-H(12C) 109.5 
H(6A)-C(6)-H(6B) 108.2 H(12B)-C(12)-H(12C) 109.5 
C(8)-C(7)-C(6) 111.7(2) C(4)-C(13)-H(13A) 109.5 
C(8)-C(7)-H(7A) 109.3 C(4)-C(13)-H(13B) 109.5 
C(6)-C(7)-H(7A) 109.3 H(13A)-C(13)-H(13B) 109.5 
C(8)-C(7)-H(7B) 109.3 C(4)-C(13)-H(13C) 109.5 
C(6)-C(7)-H(7B) 109.3 H(13A)-C(13)-H(13C) 109.5 
H(7A)-C(7)-H(7B) 107.9 H(13B)-C(13)-H(13C) 109.5 
O(8)-C(8)-C(7) 103.4(2) C(4)-C(14)-H(14A) 109.5 
O(8)-C(8)-C(12) 106.33(19) C(4)-C(14)-H(14B) 109.5 
C(7)-C(8)-C(12) 111.6(2) H(14A)-C(14)-H(14B) 109.5 
O(8)-C(8)-C(9) 105.37(19) C(4)-C(14)-H(14C) 109.5 
C(7)-C(8)-C(9) 112.1(2) H(14A)-C(14)-H(14C) 109.5 
C(12)-C(8)-C(9) 116.8(2) H(14B)-C(14)-H(14C) 109.5 
C(1')-O(8)-C(8) 116.4(2) C(10)-C(15)-H(15A) 109.5 
C(11)-C(9)-C(8) 108.90(19) C(10)-C(15)-H(15B) 109.5 
C(11)-C(9)-C(10) 116.1(2) H(15A)-C(15)-H(15B) 109.5 
C(8)-C(9)-C(10) 115.1(2) C(10)-C(15)-H(15C) 109.5 
C(11)-C(9)-H(9) 105.2 H(15A)-C(15)-H(15C) 109.5 
C(8)-C(9)-H(9) 105.2 H(15B)-C(15)-H(15C) 109.5 
C(10)-C(9)-H(9) 105.2 C(5')-C(6')-H(6'A) 109.5 
C(1)-C(10)-C(15) 110.2(2) C(5')-C(6')-H(6'B) 109.5 
C(1)-C(10)-C(9) 108.2(2) H(6'A)-C(6')-H(6'B) 109.5 
C(15)-C(10)-C(9) 112.0(2) C(5')-C(6')-H(6'C) 109.5 
C(1)-C(10)-C(5) 103.72(19) H(6'A)-C(6')-H(6'C) 109.5 
C(15)-C(10)-C(5) 114.2(2) H(6'B)-C(6')-H(6'C) 109.5 
C(9)-C(10)-C(5) 108.0(2)   
 
Table S7. Torsion angles (°) for 1.  
O(1)-C(1)-C(2)-C(3) 110.2(3) C(2)-C(1)-C(10)-C(5) 59.2(3) 
C(10)-C(1)-C(2)-C(3) -62.1(3) C(11)-C(9)-C(10)-C(1) 68.5(3) 
C(1)-C(2)-C(3)-O(3) -63.2(3) C(8)-C(9)-C(10)-C(1) -162.7(2) 
C(1)-C(2)-C(3)-C(4) 56.6(3) C(11)-C(9)-C(10)-C(15) -53.2(3) 
O(3)-C(3)-C(4)-C(14) -166.0(2) C(8)-C(9)-C(10)-C(15) 75.6(3) 
C(2)-C(3)-C(4)-C(14) 72.7(3) C(11)-C(9)-C(10)-C(5) -179.9(2) 
O(3)-C(3)-C(4)-C(13) -50.0(3) C(8)-C(9)-C(10)-C(5) -51.0(3) 
C(2)-C(3)-C(4)-C(13) -171.2(2) C(6)-C(5)-C(10)-C(1) 171.7(2) 
O(3)-C(3)-C(4)-C(5) 68.6(3) C(4)-C(5)-C(10)-C(1) -55.3(3) 
C(2)-C(3)-C(4)-C(5) -52.7(3) C(6)-C(5)-C(10)-C(15) -68.2(3) 
C(14)-C(4)-C(5)-C(6) 63.0(3) C(4)-C(5)-C(10)-C(15) 64.8(3) 
C(13)-C(4)-C(5)-C(6) -56.4(3) C(6)-C(5)-C(10)-C(9) 57.1(3) 
C(3)-C(4)-C(5)-C(6) -174.5(2) C(4)-C(5)-C(10)-C(9) -169.89(19) 
C(14)-C(4)-C(5)-C(10) -68.2(3) C(8)-C(9)-C(11)-C(2') 50.4(3) 
C(13)-C(4)-C(5)-C(10) 172.4(2) C(10)-C(9)-C(11)-C(2') -177.8(2) 
C(3)-C(4)-C(5)-C(10) 54.3(3) C(8)-O(8)-C(1')-O(5') 170.0(2) 
C(10)-C(5)-C(6)-C(7) -62.2(3) C(8)-O(8)-C(1')-C(2') -9.6(4) 
C(4)-C(5)-C(6)-C(7) 164.1(2) O(8)-C(1')-C(2')-C(3') 167.1(2) 
C(5)-C(6)-C(7)-C(8) 58.8(3) O(5')-C(1')-C(2')-C(3') -12.4(4) 
C(6)-C(7)-C(8)-O(8) -164.7(2) O(8)-C(1')-C(2')-C(11) -8.5(4) 
C(6)-C(7)-C(8)-C(12) 81.4(3) O(5')-C(1')-C(2')-C(11) 171.9(2) 
C(6)-C(7)-C(8)-C(9) -51.7(3) C(9)-C(11)-C(2')-C(1') -13.4(3) 
C(7)-C(8)-O(8)-C(1') 163.9(2) C(9)-C(11)-C(2')-C(3') 171.0(2) 
C(12)-C(8)-O(8)-C(1') -78.5(3) C(1')-C(2')-C(3')-O(3') -171.7(3) 
C(9)-C(8)-O(8)-C(1') 46.1(3) C(11)-C(2')-C(3')-O(3') 3.9(4) 
O(8)-C(8)-C(9)-C(11) -66.6(2) C(1')-C(2')-C(3')-C(4') 5.5(4) 
C(7)-C(8)-C(9)-C(11) -178.4(2) C(11)-C(2')-C(3')-C(4') -178.9(2) 
C(12)-C(8)-C(9)-C(11) 51.1(3) O(3')-C(3')-C(4')-C(5') -155.0(3) 
O(8)-C(8)-C(9)-C(10) 161.1(2) C(2')-C(3')-C(4')-C(5') 27.8(3) 
C(7)-C(8)-C(9)-C(10) 49.3(3) C(3')-C(4')-C(5')-O(5') -54.6(3) 
C(12)-C(8)-C(9)-C(10) -81.2(3) C(3')-C(4')-C(5')-C(6') -173.7(3) 
O(1)-C(1)-C(10)-C(15) 124.3(3) O(8)-C(1')-O(5')-C(5') 163.5(2) 
C(2)-C(1)-C(10)-C(15) -63.5(3) C(2')-C(1')-O(5')-C(5') -16.9(4) 
O(1)-C(1)-C(10)-C(9) 1.6(3) C(4')-C(5')-O(5')-C(1') 50.0(3) 
C(2)-C(1)-C(10)-C(9) 173.7(2) C(6')-C(5')-O(5')-C(1') 174.3(2) 
O(1)-C(1)-C(10)-C(5) -112.9(3)   
 
  
Table S8. Anisotropic atomic displacement parameters (Å2 x 103) for 1.   
The anisotropic atomic displacement factor exponent takes the form: -2π2[ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
 U11 U22 U33 U23 U13 U12 
C(1) 26(1) 20(1) 24(1) 3(1) 10(1) 3(1) 
O(1) 32(1) 33(1) 28(1) -7(1) 13(1) -6(1) 
C(2) 33(1) 34(2) 25(1) 0(1) 16(1) -2(1) 
C(3) 30(2) 35(2) 38(2) 2(1) 22(1) 1(1) 
O(3) 50(1) 36(1) 38(1) 1(1) 27(1) 7(1) 
C(4) 24(1) 33(2) 30(1) 3(1) 14(1) -3(1) 
C(5) 24(1) 24(1) 25(1) 1(1) 12(1) -4(1) 
C(6) 26(1) 36(2) 24(1) 1(1) 11(1) -3(1) 
C(7) 29(1) 35(2) 22(1) 2(1) 11(1) -5(1) 
C(8) 28(1) 32(2) 27(1) 2(1) 16(1) -5(1) 
O(8) 25(1) 38(1) 27(1) 6(1) 12(1) -6(1) 
C(9) 25(1) 22(1) 25(1) -1(1) 12(1) -3(1) 
C(10) 23(1) 24(1) 24(1) 0(1) 12(1) -3(1) 
C(11) 27(1) 29(1) 25(1) 2(1) 14(1) -2(1) 
C(1') 27(1) 36(2) 31(1) -2(1) 17(1) -4(1) 
C(2') 26(1) 33(2) 28(1) -1(1) 15(1) -2(1) 
C(3') 29(1) 38(2) 32(1) 0(1) 19(1) -1(1) 
O(3') 28(1) 54(1) 42(1) 15(1) 17(1) 3(1) 
C(4') 26(1) 51(2) 38(2) 3(1) 16(1) -6(1) 
C(5') 30(2) 42(2) 36(2) 1(1) 16(1) -8(1) 
O(5') 28(1) 42(1) 34(1) 7(1) 17(1) -6(1) 
C(12) 39(2) 42(2) 30(1) -3(1) 21(1) -1(1) 
C(13) 28(1) 51(2) 39(2) 7(2) 17(1) 2(1) 
C(14) 31(2) 42(2) 35(2) -3(1) 15(1) -13(1) 
C(15) 31(1) 24(2) 30(1) -2(1) 16(1) -4(1) 
C(6') 36(2) 53(2) 52(2) 3(2) 22(2) -13(2) 
 
  
Table S9. Hydrogen atomic coordinates (x 104) and isotropic atomic displacement parameters 
(Å2 x 103) for 1.  
 x y z U(eq) 
H(2A) 3044 758 9997 36 
H(2B) 2805 -1320 9174 36 
H(3) 1078 853 8499 38 
H(3A) 1850(30) 4120(60) 9150(30) 53(10) 
H(5) 2649 3168 7187 29 
H(6A) 1574 1966 5294 35 
H(6B) 2352 -258 5632 35 
H(7A) 3187 2453 4944 35 
H(7B) 3274 4197 5869 35 
H(9) 4713 3177 7949 29 
H(11A) 6135 891 9273 32 
H(11B) 6006 -856 8330 32 
H(4'A) 9521 3729 9375 45 
H(4'B) 9028 2518 8190 45 
H(5') 8012 6339 8647 43 
H(12A) 4760 -54 5346 53 
H(12B) 4245 -1567 5976 53 
H(12C) 5595 -885 6591 53 
H(13A) -219 2249 6595 58 
H(13B) 94 1825 5610 58 
H(13C) 646 3910 6427 58 
H(14A) 247 -1687 6753 54 
H(14B) 1565 -2491 7513 54 
H(14C) 1097 -1990 6218 54 
H(15A) 4558 -2644 8131 41 
H(15B) 3366 -2558 6980 41 
H(15C) 3333 -2817 8132 41 
H(6'A) 8351 8223 7326 69 
H(6'B) 8964 6057 7151 69 
H(6'C) 9567 7362 8313 69 
 
Table S10. Hydrogen bond distances (Å) and angles (°) for 1.  
 Donor-H Acceptor-H Donor-Acceptor Angle 
O3-H3A...O3′ #1 0.88(3) 1.94(4) 2.782(3) 161 (3) 
 
Symmetry transformations used to generate equivalent atoms:  
 #1 -x+1,y+1/2,-z+2    
